Latest Regulatory Engagement News

Netlinkz Limited reports $2.4 million in quarterly receipts and announces a strategic joint venture in the Philippines, enhancing its cybersecurity footprint in the ASEAN region with innovative network solutions.

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

GTN Limited is set to seek shareholder approval for a substantial $44 million capital return, aiming to reward investors without compromising its dividend policy.

Ardea Resources reports significant progress on the Kalgoorlie Nickel Project’s Definitive Feasibility Study, completing key drilling and advancing permitting to support a multi-decade nickel-cobalt operation.

Syntara Limited reports encouraging interim Phase 2 data for its drug SNT-5505 combined with ruxolitinib, demonstrating significant symptom relief and spleen volume reduction in myelofibrosis patients. The company plans to engage the FDA soon to discuss pivotal trial design.

Aura Energy announces a strategic collaboration with Neu Horizon Uranium Ltd to advance uranium mining in Sweden, aligning with the Swedish government’s plans to lift its uranium mining ban and bolster nuclear energy production.

Predictive Discovery faces revocation of key exploration permits in Guinea but retains critical Bankan project permits, with exploitation application progressing through regulatory channels.

Besra Gold has appointed David Potter as Chair and Sean Williamson as Director, bolstering its board with seasoned expertise as it transitions from exploration to gold production at the Jugan Project.

Leeuwin Metals has confirmed extensive shallow, high-grade gold mineralisation across a 1.6km trend at its Evanston Prospect within the Marda Gold Project, Western Australia, setting the stage for a busy exploration season.

Chalice Mining reports significant metallurgical improvements at its Gonneville Project, boosting metal recoveries and revealing a promising iron byproduct that could enhance project economics.

Lakes Blue Energy is progressing regulatory approvals and has locked in a drilling rig for its Wombat-5 gas well, while reporting a $1.48 million operating cash outflow and maintaining $3.55 million in cash at quarter-end.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.